HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets.

Abstract
We report a case of neonatal lupus syndrome (NLS) in an in vitro fertilization induced triplet pregnancy. Echocardiographic signs of myocarditis were evident at the 21st week of gestation (w.g.) in twin I, with a subsequent development of a complete atrioventricular (AV) block at the 25th w.g.; twin III also displayed echocardiographic signs of myocarditis at the same time. Treatment with dexamethasone (4mg/day) was started at the 25th w.g. A complete echocardiographic regression of the myocarditis signs was achieved, while AV block was unaffected. Caesarian section was performed at the 31.5 w.g. after a premature rupture of the membranes. Complete AV block was confirmed in twin I with a heart rate of 51 beats/min that required a pacemaker implant 40 days after. Twin III developed a first-degree AV block that switched to a periodic second-degree block later, while twin II displayed only liver enzyme abnormalities.
AuthorsV Fesslova, S Mannarino, P Salice, C Boschetto, L Trespidi, B Acaia, F Mosca, R Cimaz, P L Meroni
JournalLupus (Lupus) Vol. 12 Issue 10 Pg. 775-8 ( 2003) ISSN: 0961-2033 [Print] England
PMID14596427 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Antinuclear
  • SS-A antibodies
Topics
  • Adult
  • Antibodies, Antinuclear (blood)
  • Cardiomegaly (diagnostic imaging, etiology, immunology)
  • Echocardiography
  • Female
  • Heart Block (diagnostic imaging, etiology, immunology)
  • Humans
  • Infant, Newborn
  • Lupus Erythematosus, Systemic (complications, immunology)
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (diagnostic imaging, etiology, immunology)
  • Triplets

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: